XBIOTECH INC. (XBIT) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | -45.13M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-45.13M | (m) |
| 2026-03-31 | (m) | $-40.16M | (m) |
| 2025-12-31 | (m) | $-45.54M | (m) |
| 2025-09-30 | (m) | $-29.16M | (m) |
| 2025-06-30 | (m) | $-28.16M | (m) |
| 2025-03-31 | (m) | $-39.41M | (m) |
| 2024-12-31 | (m) | $-38.53M | (m) |
| 2024-09-30 | (m) | $-32.66M | (m) |
| 2024-06-30 | (m) | $-35.01M | (m) |
| 2024-03-31 | (m) | $-30.74M | (m) |
| 2023-12-31 | (m) | $-24.56M | (m) |
| 2023-09-30 | (m) | $4.38M | (m) |
| 2023-06-30 | (m) | $-914.00K | (m) |
| 2023-03-31 | (m) | $-3.82M | (m) |
| 2022-12-31 | $0.00 | $-32.90M | 0.00% |
| 2022-09-30 | $0.00 | $-36.16M | 0.00% |
| 2022-06-30 | (m) | $-26.77M | (m) |
| 2022-03-31 | (m) | $-20.24M | (m) |
| 2021-12-31 | $75.00M | $-17.41M | -430.71% |
| 2021-09-30 | (m) | $-12.79M | (m) |
| 2021-06-30 | (m) | $-12.05M | (m) |
| 2021-03-31 | (m) | $-13.78M | (m) |
| 2020-12-31 | (m) | $-11.22M | (m) |
| 2020-09-30 | (m) | $677.11M | (m) |
| 2020-06-30 | (m) | $673.49M | (m) |
| 2020-03-31 | (m) | $674.48M | (m) |
| 2019-12-31 | (m) | $668.63M | (m) |
| 2019-09-30 | (m) | $-23.98M | (m) |
| 2019-06-30 | (m) | $-22.88M | (m) |
| 2019-03-31 | (m) | $-22.93M | (m) |
| 2018-12-31 | (m) | $-21.14M | (m) |
| 2018-09-30 | (m) | $-22.28M | (m) |
| 2018-06-30 | (m) | $-23.43M | (m) |
| 2018-03-31 | (m) | $-26.66M | (m) |
| 2017-12-31 | (m) | $-33.15M | (m) |
| 2017-09-30 | (m) | $-40.26M | (m) |
| 2017-06-30 | (m) | $-46.54M | (m) |
| 2017-03-31 | (m) | $-51.03M | (m) |
| 2016-12-31 | (m) | $-50.72M | (m) |
| 2016-09-30 | (m) | $-48.25M | (m) |
| 2016-06-30 | (m) | $-46.50M | (m) |
| 2016-03-31 | (m) | $-39.63M | (m) |
| 2015-12-31 | (m) | $-37.48M | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) |
| 2014-12-31 | (m) | $-21.72M | (m) |
| 2014-09-30 | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) |
| 2013-12-31 | (m) | $-9.93M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |